Detalles de la búsqueda
1.
Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitor.
Mult Scler
; 29(11-12): 1471-1481, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37626477
2.
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study.
Mult Scler
; 29(14): 1808-1818, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37978852
3.
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets.
Eur J Neurol
; 30(1): 179-186, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36168741
4.
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies.
Mult Scler
; 28(1): 111-120, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33969750
5.
Prevalence of disability improvement in relapsing-remitting multiple sclerosis patients treated with cladribine tablets.
Eur J Neurol
; 29(7): 2144-2147, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35258154
6.
Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.
Neurol Ther
; 13(3): 497-499, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376607
7.
Cognitive impairment and its impact on employment: A qualitative interview-based study involving healthcare professionals and people living with multiple sclerosis.
Mult Scler Relat Disord
; 87: 105631, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38823313
8.
What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.
Neurol Ther
; 12(5): 1419-1429, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37466762
9.
Summary of Research: Caregiver Involvement in MS: Duty or Disruption?
Neurol Ther
; 12(5): 1431-1434, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37341902
10.
Assessing the duration of EDSS improvement after a therapy start: A novel approach applied to the long-term extension of the PRISMS study.
Mult Scler Relat Disord
; 79: 104945, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37651814
11.
Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care.
Adv Ther
; 40(12): 5131-5136, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37812333
12.
Identification of an agrin mutation that causes congenital myasthenia and affects synapse function.
Am J Hum Genet
; 85(2): 155-67, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19631309
13.
Pure alexia in a patient with multiple sclerosis.
Neurol Sci
; 38(3): 511-513, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27770273
14.
Caregiver Involvement in MS: Duty or Disruption?
Neurol Ther
; 11(1): 9-20, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34792783
15.
Relapses in people with multiple sclerosis treated with cladribine tablets followed for up to 5 years: a plain language summary.
Neurodegener Dis Manag
; 12(6): 303-310, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36017797
16.
Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis.
Mult Scler Relat Disord
; 57: 103385, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158476
17.
Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives.
Patient Prefer Adherence
; 15: 15-27, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33447018
18.
Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis.
Neurol Ther
; 9(1): 1-10, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31748873
19.
Publisher Correction: Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.
Neurol Ther
; 13(3): 501, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38502463
20.
Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care.
Adv Ther
; 36(11): 3238-3252, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31487006